FEATURE ARTICLES
A sponsor should approach diversion risk by embedding controls into the three phases of the CDMO relationship: selection, the agreement, and ongoing management.
- Why CMC Must Shape Critical Decisions Early In Development
- Developing Your Vapor Phase Hydrogen Peroxide Cycle
- AI In Action: Evaluating Project Assessment
- IT/OT Convergence Could Lighten Biopharma's Automation Burden
- How Peptides Are Expanding The Possibilities Of Drug Discovery
- The 2026 Pharma R&D AI Sourcing Map: Partnerships, Concentration, Inflection
- Beyond The Plate Count: How To Build A Defensible Environmental Monitoring Trend Review
PHARMA ONLINE WHITE PAPERS
-
Navigating Digital Transformation For Pharmaceutical CDMOs
Discover how CDMOs can modernize operations, safeguard data integrity, and improve audit readiness with practical strategies for connecting systems and reducing validation burdens.
-
Incremental Adoption Of A Modular Operations Platform1/31/2025
Discover the potential of a modular operations platform that scales the benefits of digitalization and aids organizations in implementing a unified data strategy to realize the full potential of smart manufacturing.
-
If You Can't Win The Game, Change It12/11/2024
Explore how eData sharing is used in the biopharma market, enabling standardized, collaborative supply chains that reduce risks and enhance visibility while improving capacity planning.
-
A Guide To Process Transparency In Custom Lab Automation Development3/16/2026
Discover a practical guide to building custom automation systems with clarity and confidence, as well as how transparent processes reduce risk, prevent misalignment, and support reliable testing.
-
Mixing Technologies For The Production Of Low To High Viscosity Adhesives4/28/2026
Understand how high shear and planetary mixing technologies optimize adhesive production. Learn to reduce cycle times, eliminate defects, and balance efficiency with your specific viscosity needs.
-
The Essential Ingredient For GxP Training Innovation6/4/2026
Advanced learning tools depend entirely on the health of the underlying training matrix. Establish a clean, data-driven framework to reduce compliance risks and recover lost operational hours.
PHARMA ONLINE APP NOTES & CASE STUDIES
- Supply Chain Diversification In Biopharmaceutical Manufacturing
- A Universal Workflow Approach For Single Cell Mass Spectrometry Based Proteomics
- The Role Of Peptones In Boosting Monoclonal Antibody Production
- Seed Train Intensification Using High Cell Density Cryopreservation
- Scale-Up Approaches For Culturing Adherent Cells
NEWSLETTER ARCHIVE
- 11.19.26 -- AI In Action: Evaluating Project Assessment
- 11.19.26 -- Regulatory Strategy, Strategic Fungibility, And Workforce Readiness
- 11.18.26 -- Is It Time To Rethink Your Protein Expression Strategy?
- 11.18.26 -- OPCU: Preparing Fill-Finish Operations For Scale And Commercial Supply
- 11.18.26 -- What If The Body Could Make Its Own Medicine?
INDUSTRY NEWS
-
Let Your Voice Help Shape Pharma Manufacturing
Pharmaceutical Online hosts live virtual panels with industry experts on important topics and challenges, and we want to know what topics are important to you. Please consider taking a few minutes of your time to tell us what they are.
-
ISPE Announces 2026 FOYA Winners
These awards recognize pharmaceutical and biopharmaceutical manufacturing projects that demonstrate excellence across innovation, operations, supply chain, Pharma 4.0, and social impact.
-
Høeg In, Pazdur Out At The FDA
What an eventful week it has been at the FDA, with Richard Pazdur, M.D., resigning after weeks in his position as director of Center for Drug Research and Evaluation (CDER), and his vacancy being quickly filled by acting director Tracy Beth Høeg, M.D.
EDITORIAL COLLECTIONS
Our curated Editorial Collections bring expert insights together in one place, offering practical perspectives and actionable guidance to help you navigate complex decisions and improve performance.
More Editorial CollectionsSUPPLIER NEWS
-
Inside information: Nanoform Selects Global CDMO Partner For GMP Manufacturing Of Ultra-High-Concentration Biologics11/17/2026
Nanoform Finland Plc (“Nanoform”), the medicine performance-enhancing company, announced today that it has signed an agreement with a CDMO partner for implementation of Nanoform’s biologics technology at one of the Partner’s European facilities for aseptic manufacturing and fill and finish of biological products.
-
Lonza Signs Agreement To Acquire US CDMO Network From Merck KGaA, Darmstadt, Germany, And Significantly Expands Its US Presence11/3/2026
Lonza, the world’s leading contract development and manufacturing organization (CDMO), announced today that it has signed a definitive agreement to acquire five CDMO manufacturing sites in the US from Merck KGaA, Darmstadt, Germany at a total enterprise valuation in the low- to mid-triple-digit millions Swiss francs.
-
Bracco To Build New Injectable Drug Manufacturing Facility In North Carolina11/2/2026
Bracco, a global leader in diagnostic imaging, today announced plans to invest $230 million to establish its first U.S. manufacturing facility for injectable contrast media in Sanford, North Carolina. Expected to create 200 jobs, the investment marks a significant milestone in Bracco's global manufacturing strategy, expanding production capacity and strengthening supply chain resilience in the United States, the company's largest market.
-
Lonza Further Expands Bioconjugation Manufacturing To Support Growing ADC Demand10/29/2026
Lonza, the world’s leading contract development and manufacturing organization (CDMO), announced today the further expansion of its integrated bioconjugation manufacturing offering. Lonza is combining the flexibility of mid-scale bioconjugation manufacturing with its previously announced large-scale bioconjugation expansion in Visp (CH), which will now include three multiproduct suites. Together, these capabilities will offer customers a scalable manufacturing pathway from clinical development through commercial supply for antibody-drug conjugates (ADCs) and other bioconjugates.
-
ROSS Portable High Shear Mixing System10/29/2026

